This is a routine PDMR share vesting and tax-cover sale with no trading signal. The insider retained the majority of vested shares (14,039 of 23,202), which is neutral. Monitor next quarterly earnings for operational updates.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 12 $29.84entry
- T+1 · 3mo ago +0.90%α +0.21% · $30.11
- T+5 · 3mo ago −1.78%α −1.33% · $29.31
- T+20 · 2mo ago −7.44%α −5.54% · $27.62
- T+60 · 12d ago +7.27%α +12.38% · $32.01
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Smith & Nephew filed a 6-K reporting the vesting of 2023 Performance Share Awards under the Global Share Plan 2020 for PDMR Rohit Kashyap, President of Advanced Wound Management and Global Commercial Operations. On August 12, 2026, 23,202 ordinary shares vested at £11.096264 per share, of which 9,163 were sold to cover tax liabilities and 14,039 were retained. This is a routine administrative disclosure of equity compensation vesting with no material new information about the company's financial or operational performance.
Key Facts
- Rohit Kashyap (PDMR) had 23,202 ordinary shares vest on August 12, 2026 under the Smith & Nephew Global Share Plan 2020.
- Of the vested shares, 9,163 were sold to cover tax liabilities and 14,039 were retained.
- Vesting price was £11.096264 per share on the London Stock Exchange.
- The remaining shares under the 2023 Performance Share Award have lapsed.
- Filing is a routine notification under UK Market Abuse Regulation with no financial or operational updates.
Financial Impact
No material financial impact, routine equity compensation vesting with tax-motivated share sales.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-007504 |
| Document: 0001654954-26-007504-index-headers.html | 0001654954-26-007504 |
| Document: 0001654954-26-007504-index.html | 0001654954-26-007504 |
| Document: 0001654954-26-007504.txt | 0001654954-26-007504 |
Track record
42 reports on SNN
6 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +8.02% at T+20 after the Jun 30, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 12, 20264d ago 6-K Neutral 1/10 Entry $31.00 Now $30.97 −0.10% settles Nov 19
- Nov 4, 202612d ago 6-K Bearish 6/10 No price data
- Nov 4, 202612d ago 6-K Bearish 6/10 Entry $32.46 to $31.04 Now $30.97 +4.59% ▲ +4.37% +3.46% vs SPY
- Nov 2, 202614d ago 6-K Neutral 4/10 Entry $30.24 to $31.05 Now $30.97 +2.41% ▲ +2.68% +2.60% vs SPY
- Oct 22, 202625d ago 6-K Neutral 2/10 Entry $30.88 to $30.22 Now $30.97 +0.29% ▼ −2.14% −2.84% vs SPY
- Oct 8, 20265w ago 6-K Neutral 2/10 Entry $26.96 to $29.09 Now $30.97 +14.87% ▲ +7.90% +8.18% vs SPY
- Oct 1, 20266w ago 6-K Neutral 2/10 Entry $26.58 to $26.96 Now $30.97 +16.52% ▲ +1.43% +0.13% vs SPY
- Oct 1, 20266w ago 6-K Neutral 2/10 Entry $26.58 to $26.96 Now $30.97 +16.52% ▲ +1.43% +0.13% vs SPY
- Sep 23, 20267w ago Press Release Neutral 3/10 Entry $26.82 to $26.96 Now $30.97 +15.47% ▲ +0.52% +1.20% vs SPY
- Sep 23, 20267w ago Press Release Neutral 3/10 Entry $26.82 to $26.96 Now $30.97 +15.47% ▲ +0.52% +1.20% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers